Is There a Role for Targeted Antibiotic Prophylaxis in Carbapenem Resistant or Extended Spectrum Betalactamase Producers (ESBL) Enterobacterales to Reduce Bloodstream Infection in Colonized Patients at Transplant?

MLA

E. Seminari, et al. “Is There a Role for Targeted Antibiotic Prophylaxis in Carbapenem Resistant or Extended Spectrum Betalactamase Producers (ESBL) Enterobacterales to Reduce Bloodstream Infection in Colonized Patients at Transplant?” The Journal of Heart and Lung Transplantation, vol. 41, Apr. 2022, p. S279. EBSCOhost, https://doi.org/10.1016/j.healun.2022.01.686.

APA

E. Seminari, M. Belliato, P. Cambieri, A. Di Matteo, F. Meloni, B. Cattadori, A. Turco, C. Pellegrini, S. Pelenghi, & R. Bruno. (2022). Is There a Role for Targeted Antibiotic Prophylaxis in Carbapenem Resistant or Extended Spectrum Betalactamase Producers (ESBL) Enterobacterales to Reduce Bloodstream Infection in Colonized Patients at Transplant? The Journal of Heart and Lung Transplantation, 41, S279. https://doi.org/10.1016/j.healun.2022.01.686

Chicago

E. Seminari, M. Belliato, P. Cambieri, A. Di Matteo, F. Meloni, B. Cattadori, A. Turco, C. Pellegrini, S. Pelenghi, and R. Bruno. 2022. “Is There a Role for Targeted Antibiotic Prophylaxis in Carbapenem Resistant or Extended Spectrum Betalactamase Producers (ESBL) Enterobacterales to Reduce Bloodstream Infection in Colonized Patients at Transplant?” The Journal of Heart and Lung Transplantation 41 (April): S279. doi:10.1016/j.healun.2022.01.686.